第四季日本手遊收入逾46億美元升34% 30款中國手遊打入暢銷榜首百位
調查機構Sensor Tower 發表的報告指,去年第四季日本手遊市場收入超過46億美元,按年增長34%,當中暢銷榜首一百位的中國手遊數量增加至30款,市場份額27%。
入圍榜單前十的中國手游多達3款,分別是網易(09999.HK)旗下的《荒野行動》、米哈遊旗下的《原神》和有愛互娛旗下的《放置少女》,由於中國廠商在遊戲運營和推廣方面擁有更多的資源投入,近兩年來中國遊戲在日本頭部市場的成功率已經超越任天堂、世嘉等本土企業。
收入方面,網易的《荒野行動》以1.4億美元位居榜首,《原神》移動端收入1.36億美元緊隨其後。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.